Summit Study
For patients between the ages of 22-75 with a confirmed diagnosis of chronic locked-in syndrome
Masks are required inside all of our care facilities. We are vaccinating all eligible patients. Learn more:
Vaccines, Boosters & Additional Doses | Testing | Patient Care | Visitor Guidelines | Coronavirus
Find more COVID-19 testing locations on Maryland.gov.
The Johns Hopkins Department of Neurology is recruiting participants for two upcoming clinical trials. Both studies will investigate brain-computed interface (BCI) systems for patients with movement and communication impairments. Dr. Nathan Crone, professor of neurology, will lead both trials.
For patients between the ages of 22-75 with a confirmed diagnosis of chronic locked-in syndrome
For patients between the ages of 22-70 who are affected by significant movement and/or communication impairments
The Summit study will test a specific BCI, the Medtronic Summit System, for patients with chronic locked-in syndrome, a disorder in which communication is impaired by severe paralysis. The goal of the study is to assess this particular BCI's ability to assist communication. To learn more about the Summit Study, call 410-955-6772.
Like the Summit Study above, this trial will also evaluate a specific BCI model. However, this study will test a different BCI, the CortiCom system. To learn more about the CortiCom Study, call 410-955-6772.
The Cortical Communication (CortiCom) System's electrical grid connects to the rest of the computer system and its software.